BullFrog AI Holdings, Inc.
Close on Oct 19, 2026
- Market cap
- $9.92M
- P/E (TTM)
- –
- Dividend yield
- –
About BullFrog AI
Pharmaceutical Preparations, SIC 2834
BullFrog AI Holdings, Inc. operates as a digital healthcare and artificial intelligence company focused on advancing biopharmaceutical development. The company utilizes its proprietary bfLEAP™ artificial intelligence and machine learning platform, derived from technology developed at The Johns Hopkins University Applied Physics Laboratory, to analyze complex pre-clinical and clinical data sets. Its business model centers on contract services, providing fee-for-service analytics to biopharmaceutical firms and other organizations, as well as collaborative arrangements and the internal development of acquired drug assets targeting various oncology and liver disease indications.
The company operates primarily through BullFrog AI Holdings, Inc., alongside its subsidiaries BullFrog AI, Inc. and BullFrog AI Management, LLC. It holds exclusive intellectual property licenses with institutions such as The Johns Hopkins University and George Washington University. BullFrog AI maintains its principal executive offices and headquarters in Gaithersburg, Maryland.
Summary of the business section of BullFrog AI's latest annual report, written by StockData.
Company profile
Company
- Legal name
- BullFrog AI Holdings, Inc.
- Founded
- 2020
- Headquarters
- Gaithersburg, MD
- Address
- 325 Ellington Blvd., Unit 317 20878
- Phone
- (301) 367-2055
- Website
- bullfrogai.com
- Employees
- 9, Dec 31, 2025
- Industry
- Pharmaceutical Preparations
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- M&K CPAS, PLLC, The Woodlands, Texas
Stock & identifiers
- Ticker
- BFRG
- Other tickers
- BFRGW
- Exchange
- Nasdaq
- IPO date
- Feb 16, 2023
- Shares outstanding
- 19M, Aug 13, 2026
- Public float
- $11.00M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- SEC CIK
- 1829247
- CUSIP
- 12021E109
- ISIN
- US12021E1091
- EIN
- 84-4786155
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Vininder Singh | Chief Executive Officer, Director | 2,442,446 |
| Joshua Blacher | Chief Financial Officer | 65,000 |
| R. Don Elsey | Director | 5,710 |
| Jason David Hanson | Director | 8,523 |
| William Enright | Director | 13,523 |
Employees
Headcount reported in annual reports
“of December 31, 2025, the Company had 9 full-time employees, including its Chief Executive Officer, and 8 part-time employees, advisors,”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 20, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Feb 23, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Feb 17, 2026 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Oct 9, 2025 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Aug 27, 2025 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| May 26, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| May 16, 2023 | Late filing | Notification of late filing |
| Apr 25, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Apr 3, 2023 | Late filing | Notification of late filing |
| Feb 16, 2023 | IPO | Initial public offering priced (424B4 prospectus) |
| Jan 23, 2023 | Listing | Registration of securities on an exchange (Form 8-A) |